Search research articles
Contact Us
Filters
Showing results (241-250 of 257) with videos related to
Page
of 26
Sort By:
Diagnostic Microbiology and Infectious Disease
|
October 27, 2012
Molecular characterization of vancomycin-resistant Enterococcus spp. clinical isolates recovered from hospitalized patients among several medical institutions in China
Hongli Sun, Hui Wang, Yingchun Xu, et al.
Journal of Clinical Microbiology
|
November 10, 2006
Rapid detection and identification of metallo-beta-lactamase-encoding genes by multiplex real-time PCR assay and melt curve analysis
Rodrigo E Mendes, Katia A Kiyota, Jussimara Monteiro, et al.
The Journal of Infection
|
August 3, 2020
Streptococcus pneumoniae serotype distribution and antimicrobial nonsusceptibility trends among adults with pneumonia in the United States, 2009‒2017
Jose A Suaya, Rodrigo E Mendes, Heather L Sings, et al.
Diagnostic Microbiology and Infectious Disease
|
February 28, 2019
Ceftobiprole activity when tested against contemporary bacteria causing bloodstream infections in the United States (2016-2017)
Michael A Pfaller, Robert K Flamm, Leonard R Duncan, et al.
Antimicrobial Agents and Chemotherapy
|
May 23, 2024
Patient outcomes by baseline pathogen resistance phenotype and genotype in CERTAIN-1, a Phase 3 study of cefepime-taniborbactam versus meropenem in adults with complicated urinary tract infection
Greg Moeck, Leanne B Gasink, Rodrigo E Mendes, et al.
Antimicrobial Agents and Chemotherapy
|
October 31, 2018
Ceftobiprole Activity against Gram-Positive and -Negative Pathogens Collected from the United States in 2006 and 2016
Michael A Pfaller, Robert K Flamm, Rodrigo E Mendes, et al.
Antimicrobial Agents and Chemotherapy
|
August 21, 2013
Regional resistance surveillance program results for 12 Asia-Pacific nations (2011)
Rodrigo E Mendes, Myrna Mendoza, Kirnpal K Banga Singh, et al.
Microbiology Spectrum
|
October 13, 2025
Activity of cefiderocol against <i>Pseudomonas aeruginosa</i> from the USA and Europe (2020-2023) with difficult-to-treat resistance phenotype, including those nonsusceptible to recently developed β-lactam/β-lactamase inhibitor combinations: results from the SENTRY antimicrobial surveillance program
John H Kimbrough, Maura H Karr, Sean T Nguyen, et al.
Antimicrobial Agents and Chemotherapy
|
July 30, 2014
Relationship between ceftolozane-tazobactam exposure and selection for Pseudomonas aeruginosa resistance in a hollow-fiber infection model
Brian D VanScoy, Rodrigo E Mendes, Mariana Castanheira, et al.
Antimicrobial Agents and Chemotherapy
|
June 19, 2013
Relationship between ceftolozane-tazobactam exposure and drug resistance amplification in a hollow-fiber infection model
Brian Vanscoy, Rodrigo E Mendes, Mariana Castanheira, et al.
Page
of 26
Search research articles
Search
Showing results (241-250 of 257) with videos related to
Sort By:
Page
of 26
Diagnostic Microbiology and Infectious Disease
|
October 27, 2012
Molecular characterization of vancomycin-resistant Enterococcus spp. clinical isolates recovered from hospitalized patients among several medical institutions in China
Hongli Sun, Hui Wang, Yingchun Xu, et al.
Journal of Clinical Microbiology
|
November 10, 2006
Rapid detection and identification of metallo-beta-lactamase-encoding genes by multiplex real-time PCR assay and melt curve analysis
Rodrigo E Mendes, Katia A Kiyota, Jussimara Monteiro, et al.
The Journal of Infection
|
August 3, 2020
Streptococcus pneumoniae serotype distribution and antimicrobial nonsusceptibility trends among adults with pneumonia in the United States, 2009‒2017
Jose A Suaya, Rodrigo E Mendes, Heather L Sings, et al.
Diagnostic Microbiology and Infectious Disease
|
February 28, 2019
Ceftobiprole activity when tested against contemporary bacteria causing bloodstream infections in the United States (2016-2017)
Michael A Pfaller, Robert K Flamm, Leonard R Duncan, et al.
Antimicrobial Agents and Chemotherapy
|
May 23, 2024
Patient outcomes by baseline pathogen resistance phenotype and genotype in CERTAIN-1, a Phase 3 study of cefepime-taniborbactam versus meropenem in adults with complicated urinary tract infection
Greg Moeck, Leanne B Gasink, Rodrigo E Mendes, et al.
Antimicrobial Agents and Chemotherapy
|
October 31, 2018
Ceftobiprole Activity against Gram-Positive and -Negative Pathogens Collected from the United States in 2006 and 2016
Michael A Pfaller, Robert K Flamm, Rodrigo E Mendes, et al.
Antimicrobial Agents and Chemotherapy
|
August 21, 2013
Regional resistance surveillance program results for 12 Asia-Pacific nations (2011)
Rodrigo E Mendes, Myrna Mendoza, Kirnpal K Banga Singh, et al.
Microbiology Spectrum
|
October 13, 2025
Activity of cefiderocol against <i>Pseudomonas aeruginosa</i> from the USA and Europe (2020-2023) with difficult-to-treat resistance phenotype, including those nonsusceptible to recently developed β-lactam/β-lactamase inhibitor combinations: results from the SENTRY antimicrobial surveillance program
John H Kimbrough, Maura H Karr, Sean T Nguyen, et al.
Antimicrobial Agents and Chemotherapy
|
July 30, 2014
Relationship between ceftolozane-tazobactam exposure and selection for Pseudomonas aeruginosa resistance in a hollow-fiber infection model
Brian D VanScoy, Rodrigo E Mendes, Mariana Castanheira, et al.
Antimicrobial Agents and Chemotherapy
|
June 19, 2013
Relationship between ceftolozane-tazobactam exposure and drug resistance amplification in a hollow-fiber infection model
Brian Vanscoy, Rodrigo E Mendes, Mariana Castanheira, et al.
Page
of 26